Goldman Sachs Group Inc Biote Corp. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Biote Corp. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 66,178 shares of BTMD stock, worth $187,283. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66,178
Previous 113,339
41.61%
Holding current value
$187,283
Previous $377,000
29.44%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BTMD
# of Institutions
97Shares Held
16.5MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$12.9 Million8.28% of portfolio
-
Bandera Partners LLC New York, NY2.28MShares$6.46 Million4.11% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$4.54 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$4.03 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA685KShares$1.94 Million0.01% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $21.4M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...